Lu AF88434 / Lundbeck - LARVOL DELTA

Study Investigating the Safety and Tolerability of Lu AF88434 in Healthy Young Men (clinicaltrials.gov) - P1; N=68; Completed; Sponsor: H. Lundbeck A/S; Recruiting ➔ Completed; Trial completion date: Mar 2020 ➔ Sep 2020; Trial primary completion date: Mar 2020 ➔ Sep 2020

Clinical • Trial completion • Trial completion date • Trial primary completion date

A Study in Healthy Men to Investigate Uptake and Distribution of Lu AF88434 in the Brain (clinicaltrials.gov) - P1; N=8; Completed; Sponsor: H. Lundbeck A/S; Recruiting ➔ Completed

Clinical • Trial completion

A Study in Healthy Men to Investigate Uptake and Distribution of Lu AF88434 in the Brain (clinicaltrials.gov) - P1; N=8; Recruiting; Sponsor: H. Lundbeck A/S

Clinical • New P1 trial